Stimcell Energetics Inc. (formerly Cell MedX Corp.) reported a significant increase in its net loss for the fiscal year ending May 31, 2025, amounting to $566,293, compared to a loss of $142,486 in the previous year. The company did not generate any revenue during this period, maintaining a working capital deficit of $1,246,286, which reflects a 50.8% increase from the prior year. Operating expenses surged by 94.6% to $522,106, driven primarily by a 384% increase in research and development costs, which rose to $64,009 as the company engaged ADM Tronics Unlimited, Inc. to redesign its eBalance® Home device.
The company underwent a corporate restructuring, including a 1-for-15 reverse stock split and a name change to Stimcell Energetics Inc. on November 1, 2024. This restructuring aimed to stabilize the company's financial position and enhance its market presence. Despite these efforts, the company suspended its research and development activities related to the eBalance® Technology due to financial constraints, leading to the cancellation of its Health Canada Class II Medical Device System Certification licenses.
In terms of operational metrics, the company has not reported any customer counts or user statistics for its eBalance® systems, as all revenue-generating activities were suspended following the cancellation of its medical device licenses. The company’s employee count remains limited, with no full-time employees other than its executive officers, who serve as independent consultants. The company is currently focused on redesigning its eBalance® device to make it more accessible to consumers, with plans to launch a compact, affordable version by early 2026.
Looking ahead, Stimcell Energetics Inc. faces substantial challenges, including the need for additional financing to support its operations and research initiatives. The company has expressed uncertainty regarding its ability to raise the necessary capital, which is critical for its survival and future growth. Management's plans include seeking equity or debt financing to continue operations and potentially achieve profitable operations in the future. However, the company has accumulated a deficit of $10,861,556 since its inception, raising concerns about its long-term viability.
About Stimcell Energetics Inc.
Stimcell Energetics Inc. develops microcurrent-based devices aimed at enhancing cellular function, wellness, and managing health conditions such as diabetes, pain, and neuropathy. Its proprietary eBalance® technology supports health through electrical therapy systems for clinical and home use. The company focuses on research, regulatory approval, and commercialization of its medical devices, targeting chronic disease management and wellness markets worldwide.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.